ArticleJournal of clinical medicine2022

Serum Visfatin/NAMPT as a Potential Risk Predictor for Malignancy of Adrenal Tumors.

Nadia Sawicka-Gutaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.